3
5/18/2018 HumanLeukocyteAntigenandPlateletImmunology-slidepdf.com http://slidepdf.com/reader/full/human-leukocyte-antigen-and-platelet-immunology 1/ Human Leukocyte Antigen and Platelet Immunology Human Leukocyte Antigen HLA antigens and antibodies are also involved in transfusion and transplantation medicine Responsible for reactions that causes chills and fever in red cell transfusion  The genes are part of Major Histocompatibility Complex (MHC located in Chromosome no! " #nd to A$% compatibility in organ transplant& important in the survival of 'idney& heart and lung transplants ssential in recognition of self and non)self& and coordination of cellular and humoral immunity& and the immune response to antigens *aming of HLA antigens consist of letter designating the locus+ A& $& C& ,R& ,-& ,.& and a number of indicating A#& $#/& C0/& ,R1& ,-2  Testing and Identifcation Antibodies 3denti4ed by agglutination or hemagglutination test Class 3) found in surface of platelets& leu'ocytes and most nucleated cells (Mature red cells lac' HLA Ag Class 33 ) found in antigen presenting cells ) macrophages& dendritic cells& and $)cells5 not found in platelets  Serologic Typing 6uspension of $ or T lymphocytes is added to microtiter plates containing 'no7n antibody speci4cities! After incubation& a rabbit complement is added 3f the Ab on the plate matches the Ag on the cell& complement is activated causing cell injury or a positive reaction Cell damage is detected by the addition of a dye ) injury allo7s the dye to enter the cell and visual means to see (8 cells ach 7ell is seen under the microscope and identi4ed 7hether Class 3 or 33  Sensitization o HLA Ag .regnancies+ about 9:)2:; of 7omen 7ith 9 or more pregnancies develop HLA antibodies $lood transfusion+ about 2:< of patients 7ho receive multiple transfusions develop A$! Thus& leu'ocyte reduced blood may decrease sensiti=ation! .revious transplant+ about >:< of patients develop HLA antibodies 7ithin # 7ee's of failed graft  Therefore& cross)matching 7ith the recipient serum 7ith T cells and $ cells from the potential donor is important to avoid rejection and ?raft)versus)host disease (?@H, o ?@H, ) occurs 7hen a grafter immunocompetent cells from a donor mount an immune response against a host tissue o 6ymptoms+ diarrhea& rash and jaundice o Can also occur in immunocompromised patients

Human Leukocyte Antigen and Platelet Immunology

Embed Size (px)

DESCRIPTION

Blood Bank

Citation preview

Human Leukocyte Antigen and Platelet Immunology

Human Leukocyte Antigen HLA antigens and antibodies are also involved in transfusion and transplantation medicine Responsible for reactions that causes chills and fever in red cell transfusion The genes are part of Major Histocompatibility Complex (MHC) located in Chromosome no. 6 2nd to ABO compatibility in organ transplant, important in the survival of kidney, heart and lung transplants Essential in recognition of self and non-self, and coordination of cellular and humoral immunity, and the immune response to antigens Naming of HLA antigens consist of letter designating the locus: A, B, C, DR, DQ, DP, and a number of indicating A2, B27, CW7, DR1, DQ5Testing and Identification of Antibodies Identified by agglutination or hemagglutination test Class I- found in surface of platelets, leukocytes and most nucleated cells (Mature red cells lack HLA Ag) Class II - found in antigen presenting cells - macrophages, dendritic cells, and B-cells; not found in plateletsSerologic Typing Suspension of B or T lymphocytes is added to microtiter plates containing known antibody specificities. After incubation, a rabbit complement is added If the Ab on the plate matches the Ag on the cell, complement is activated causing cell injury or a positive reaction

Cell damage is detected by the addition of a dye - injury allows the dye to enter the cell and visual means to see (+) cells Each well is seen under the microscope and identified whether Class I or IISensitization of HLA Ag Pregnancies: about 30-50& of women with 3 or more pregnancies develop HLA antibodies Blood transfusion: about 50% of patients who receive multiple transfusions develop AB. Thus, leukocyte reduced blood may decrease sensitization. Previous transplant: about 90% of patients develop HLA antibodies within 2 weeks of failed graft Therefore, cross-matching with the recipient serum with T cells and B cells from the potential donor is important to avoid rejection and Graft-versus-host disease (GVHD). GVHD - occurs when a grafter immunocompetent cells from a donor mount an immune response against a host tissue. Symptoms: diarrhea, rash and jaundice. Can also occur in immunocompromised patients receiving blood components from related donor. Thus, irradiation of blood components from first degree relative is performed to reduce the risk of leukocytes proliferation in the host4. Irradiation - reduce viable leukocytes from replicating

Platelet Antigens Platelets possess inherited membrane; can elicit an immune response Platelet Abs are less frequently found because of less Ag variability in the population Abs to platelets Ags are the major cause of: . Neonatal Alloimune Thrombocytopenia (NAIT) - inherited from the father; cause platelet reaction. Post Transfusion Purpura (PTP) - characterized by antibody destruction of platelets after transfusion